WASHINGTON - The Food and Drug Administration cautioned patients Friday that using large amounts of a Johnson & Johnson foot ulcer drug could enhance their menaces of fading from cancer.

The FDA appended severe warning to the J& J foot ulcer cream with respect to Regranex which is approved to treat ruthless foot and leg ulcers in diabetics. The new boxed warning demonstrates that patients who used three or more tubes of Regranex over a 20-month period were five times more likely to be a victim of cancer.

FDA elucidated that the less amount of use of the cream could mitigate the chances of cancer. It is jut like those people who don’t use the drugs of J&J foot ulcer cream. This finding has come into observation through a long research and its analysis which showed that Reganex was used by a large amount of the people.

(more…)